BR0004530A - Processo para manufaturamento de preparações oftálmicas tópicas sem efeitos sistêmicos - Google Patents
Processo para manufaturamento de preparações oftálmicas tópicas sem efeitos sistêmicosInfo
- Publication number
- BR0004530A BR0004530A BR0004530-6A BR0004530A BR0004530A BR 0004530 A BR0004530 A BR 0004530A BR 0004530 A BR0004530 A BR 0004530A BR 0004530 A BR0004530 A BR 0004530A
- Authority
- BR
- Brazil
- Prior art keywords
- topical
- preparations
- systemic
- effects
- systemic effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN90BO1999 IN185228B (el) | 1999-02-03 | 1999-02-03 | |
PCT/IN2000/000008 WO2000049990A2 (en) | 1999-02-03 | 2000-02-02 | The process for manufacturing topical ophthalmic preparations without systemic effects |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0004530A true BR0004530A (pt) | 2001-04-03 |
Family
ID=11077485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0004530-6A Pending BR0004530A (pt) | 1999-02-03 | 2000-02-02 | Processo para manufaturamento de preparações oftálmicas tópicas sem efeitos sistêmicos |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1139970A2 (el) |
AP (1) | AP2000001977A0 (el) |
AU (1) | AU4429100A (el) |
BR (1) | BR0004530A (el) |
CA (1) | CA2326690A1 (el) |
EA (1) | EA200000918A1 (el) |
ID (1) | ID28121A (el) |
IL (1) | IL138824A0 (el) |
IN (1) | IN185228B (el) |
WO (1) | WO2000049990A2 (el) |
ZA (1) | ZA200006252B (el) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8858961B2 (en) | 2000-07-14 | 2014-10-14 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
AU2005220199B2 (en) * | 2000-07-14 | 2007-03-08 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
NZ521185A (en) * | 2000-07-14 | 2005-02-25 | Allergan Inc | Compositions containing alpha-2-adrenergic agonist components |
DE10132876A1 (de) * | 2001-07-06 | 2003-01-30 | Medproject Pharma Entwicklungs | Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge |
US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
ES2647618T3 (es) | 2004-05-25 | 2017-12-22 | Galderma Pharma S.A. | Compuestos, formulaciones y procedimientos para tratar o prevenir trastornos inflamatorios de la piel |
EP2329849B1 (en) | 2009-11-18 | 2015-04-29 | Galderma Research & Development | Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
FR2977493B1 (fr) | 2011-07-05 | 2014-02-14 | Galderma Res & Dev | Nouvelle composition anesthesique stable pour la reduction des reactions cutanees |
WO2014127243A1 (en) | 2013-02-15 | 2014-08-21 | Allergan, Inc. | Sustained drug delivery implant |
WO2014150899A1 (en) * | 2013-03-15 | 2014-09-25 | Chapin Matthew J | Topical ophthalmic formulations for treating migraine |
US9421199B2 (en) | 2014-06-24 | 2016-08-23 | Sydnexis, Inc. | Ophthalmic composition |
WO2016172712A2 (en) | 2015-04-23 | 2016-10-27 | Sydnexis, Inc. | Ophthalmic composition |
US11382909B2 (en) | 2014-09-05 | 2022-07-12 | Sydnexis, Inc. | Ophthalmic composition |
US11052094B2 (en) | 2015-05-29 | 2021-07-06 | Sydnexis, Inc. | D2O stabilized pharmaceutical formulations |
GB202110420D0 (en) * | 2021-07-20 | 2021-09-01 | Rosemont Pharmaceuticals Ltd | Liquid pharmaceutical composition of clonidine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6056684B2 (ja) * | 1977-11-07 | 1985-12-11 | 東興薬品工業株式会社 | 点眼剤 |
DD294174A5 (de) * | 1990-05-04 | 1991-09-26 | Sigrid Keipert | Ophthalmika mit retardwirkung und ein neues verfahren zu ihrer herstellung |
FR2678832B1 (fr) * | 1991-07-10 | 1995-03-17 | Europhta Sa Laboratoire | Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation. |
FR2679773A1 (fr) * | 1991-07-30 | 1993-02-05 | Merck Sharp & Dohme | Preparation ophtalmique contenant un agent osmotique acceptable antimicrobien. |
DE19614823A1 (de) * | 1996-04-15 | 1997-10-16 | Mann Gerhard Chem Pharm Fab | Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge |
-
1999
- 1999-02-03 IN IN90BO1999 patent/IN185228B/en unknown
-
2000
- 2000-02-02 AP APAP/P/2000/001977A patent/AP2000001977A0/en unknown
- 2000-02-02 ID IDW20002252A patent/ID28121A/id unknown
- 2000-02-02 EP EP00925571A patent/EP1139970A2/en not_active Withdrawn
- 2000-02-02 AU AU44291/00A patent/AU4429100A/en not_active Abandoned
- 2000-02-02 IL IL13882400A patent/IL138824A0/xx unknown
- 2000-02-02 CA CA002326690A patent/CA2326690A1/en not_active Abandoned
- 2000-02-02 EA EA200000918A patent/EA200000918A1/ru unknown
- 2000-02-02 WO PCT/IN2000/000008 patent/WO2000049990A2/en not_active Application Discontinuation
- 2000-02-02 BR BR0004530-6A patent/BR0004530A/pt active Pending
- 2000-11-01 ZA ZA200006252A patent/ZA200006252B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IN185228B (el) | 2000-12-09 |
WO2000049990A3 (en) | 2001-07-26 |
AU4429100A (en) | 2000-09-14 |
ZA200006252B (en) | 2001-11-29 |
EA200000918A1 (ru) | 2001-10-22 |
IL138824A0 (en) | 2001-10-31 |
ID28121A (id) | 2001-05-03 |
EP1139970A2 (en) | 2001-10-10 |
WO2000049990A2 (en) | 2000-08-31 |
AP2000001977A0 (en) | 2000-12-31 |
CA2326690A1 (en) | 2000-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0004530A (pt) | Processo para manufaturamento de preparações oftálmicas tópicas sem efeitos sistêmicos | |
BR0307893A (pt) | Formulação oftálmica com sistema de goma | |
WO2003024433A3 (en) | Compositions for treatment of common cold, comprising ipratropium and xylometazoline | |
BR0109779A (pt) | Soluções moleculares hidrofìlicas dispersas de carvedilol | |
AR048878A1 (es) | Composiciones topicas de metadona y metodos para usarlas | |
AU2003301747A1 (en) | Pharmaceutical compositions suitable for the treatment of ophthalmic diseases | |
WO2004071469A3 (en) | Methods of administering a dermatological agent to a subject | |
BR0311867A (pt) | Forma de ministração adesiva a mucosa em forma de pelìcula e uso de um extrato ou de um óleo de cannabis para a produção de uma forma de ministração adesiva a mucosa em forma de pelìcula | |
JP2007500244A5 (el) | ||
JP2002509101A (ja) | キレート化剤を含む、オートクレーブで処理できる医薬組成物 | |
BRPI0413889A (pt) | formulação lipossÈmica farmacêutica | |
BR0214430A (pt) | Formulação de aminoácidos e riboflavina úteis para reduzir efeitos tóxicos de quimioterapia citotóxica | |
WO2006093784A3 (en) | Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents | |
BR0305628A (pt) | Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso | |
BR9814721A (pt) | "uso de polióis, dispositivo apropriado para o tratamento ou profilaxia de infecção da mucosa causada por levedura em mamìferos, processo para tratamento terapêutico ou profilático de mamìferos sofrendo de ou sendo submetidos a um risco aumentado de infecção da mucosa causada por levedura, composição para uso neste trtatamento, e, preparação farmacêutica para uso no tratamento profilático ou terapêutico sistêmico ou tópico de infecções da mucosa causadas por levedura." | |
BRPI0511067B8 (pt) | processo para a formulação de formas de dosagem de dispersão rápida e forma de dosagem oral, sólida, de desintegração rápida de uma substância farmaceuticamente ativa | |
BR0313213A (pt) | ácido silìcico precipitante altamente dispersável com superfìcie maior | |
AR056835A1 (es) | Composicion que contiene oligosacaridos | |
JP4831944B2 (ja) | プラノプロフェン含有組成物 | |
WO2003032985A3 (en) | Concomitant oral and topical administration of anti - infective agents | |
AR015744A1 (es) | Uso de dexmedetomidina para sedacion en terapia intensiva | |
AR069831A1 (es) | Composiciones y metodos para el tratamiento del cancer de vejiga | |
BR0203416A (pt) | Processo para o revestimento antibiótico de corpos com microcavidades interconectantes bem como corpos revestidos e seu emprego | |
UA89656C2 (ru) | Фармацевтическая композиция, которая диспергируется перорально, и способ ее приготовления | |
WO2023137405A3 (en) | Ultraflexible liposomes in gel formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |